lithium;3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazin-2-yl]-3-[(2R)-oxolan-2-yl]propan-1-one;methyl 3-amino-6-chloro-5-(triazol-2-yl)pyrazine-2-carboxylate;methyl 3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylate;(3-methylimidazo[1,2-a]pyridin-6-yl)boronic acid;[(2R)-oxolan-2-yl]methanamine;hydroxide

C73H76BClLiN33O12 — CID 160745245

About lithium;3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazin-2-yl]-3-[(2R)-oxolan-2-yl]propan-1-one;methyl 3-amino-6-chloro-5-(triazol-2-yl)pyrazine-2-carboxylate;methyl 3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylate;(3-methylimidazo[1,2-a]pyridin-6-yl)boronic acid;[(2R)-oxolan-2-yl]methanamine;hydroxide

lithium;3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazin-2-yl]-3-[(2R)-oxolan-2-yl]propan-1-one;methyl 3-amino-6-chloro-5-(triazol-2-yl)pyrazine-2-carboxylate;methyl 3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylate;(3-methylimidazo[1,2-a]pyridin-6-yl)boronic acid;[(2R)-oxolan-2-yl]methanamine;hydroxide (PubChem CID 160745245) has the molecular formula C73H76BClLiN33O12 and a molecular weight of 1660.84 g/mol. Its IUPAC name is lithium;3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazin-2-yl]-3-[(2R)-oxolan-2-yl]propan-1-one;methyl 3-amino-6-chloro-5-(triazol-2-yl)pyrazine-2-carboxylate;methyl 3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylate;(3-methylimidazo[1,2-a]pyridin-6-yl)boronic acid;[(2R)-oxolan-2-yl]methanamine;hydroxide.

Molecular Properties

• Compound Name: lithium;3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazin-2-yl]-3-[(2R)-oxolan-2-yl]propan-1-one;methyl 3-amino-6-chloro-5-(triazol-2-yl)pyrazine-2-carboxylate;methyl 3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylate;(3-methylimidazo[1,2-a]pyridin-6-yl)boronic acid;[(2R)-oxolan-2-yl]methanamine;hydroxide
• PubChem CID: 160745245
• Molecular Formula: C73H76BClLiN33O12
• Molecular Weight: 1660.84 g/mol
• Exact Mass: 1659.63
• IUPAC Name: lithium;3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazin-2-yl]-3-[(2R)-oxolan-2-yl]propan-1-one;methyl 3-amino-6-chloro-5-(triazol-2-yl)pyrazine-2-carboxylate;methyl 3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylate;(3-methylimidazo[1,2-a]pyridin-6-yl)boronic acid;[(2R)-oxolan-2-yl]methanamine;hydroxide
• SMILES: COC(=O)c1nc(-c2ccc3ncc(C)n3c2)c(-n2nccn2)nc1N.COC(=O)c1nc(Cl)c(-n2nccn2)nc1N.Cc1cnc2ccc(-c3nc(C(=O)CC[C@H]4CCCO4)c(N)nc3-n3nccn3)cn12.Cc1cnc2ccc(-c3nc(C(=O)O)c(N)nc3-n3nccn3)cn12.Cc1cnc2ccc(B(O)O)cn12.NC[C@H]1CCCO1.[Li+].[OH-]
• InChI: InChI=1S/C21H22N8O2.C16H14N8O2.C15H12N8O2.C8H9BN2O2.C8H7ClN6O2.C5H11NO.Li.H2O/c1-13-11-23-17-7-4-14(12-28(13)17)18-21(29-24-8-9-25-29)27-20(22)19(26-18)16(30)6-5-15-3-2-10-31-15;1-9-7-18-11-4-3-10(8-23(9)11)12-15(24-19-5-6-20-24)22-14(17)13(21-12)16(25)26-2;1-8-6-17-10-3-2-9(7-22(8)10)11-14(23-18-4-5-19-23)21-13(16)12(20-11)15(24)25;1-6-4-10-8-3-2-7(9(12)13)5-11(6)8;1-17-8(16)4-6(10)14-7(5(9)13-4)15-11-2-3-12-15;6-4-5-2-1-3-7-5;;/h4,7-9,11-12,15H,2-3,5-6,10H2,1H3,(H2,22,27);3-8H,1-2H3,(H2,17,22);2-7H,1H3,(H2,16,21)(H,24,25);2-5,12-13H,1H3;2-3H,1H3,(H2,10,14);5H,1-4,6H2;;1H2/q;;;;;;+1;/p-1/t15-;;;;;5-;;/m1....1../s1
• InChIKey: RWCPLPKFHYKNQP-BMKPWPAOSA-M
• XLogP: 0.77
• TPSA: 621.15 Ų
• H-Bond Donors: 8
• H-Bond Acceptors: 44
• Rotatable Bonds: 16
• Heavy Atoms: 121
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	1660.84
LogP ≤ 5	0.77
H-Bond Donors ≤ 5	8
H-Bond Acceptors ≤ 10	44

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of lithium;3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazin-2-yl]-3-[(2R)-oxolan-2-yl]propan-1-one;methyl 3-amino-6-chloro-5-(triazol-2-yl)pyrazine-2-carboxylate;methyl 3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylate;(3-methylimidazo[1,2-a]pyridin-6-yl)boronic acid;[(2R)-oxolan-2-yl]methanamine;hydroxide?

The IUPAC name of lithium;3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazin-2-yl]-3-[(2R)-oxolan-2-yl]propan-1-one;methyl 3-amino-6-chloro-5-(triazol-2-yl)pyrazine-2-carboxylate;methyl 3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylate;(3-methylimidazo[1,2-a]pyridin-6-yl)boronic acid;[(2R)-oxolan-2-yl]methanamine;hydroxide (CID 160745245) is lithium;3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazin-2-yl]-3-[(2R)-oxolan-2-yl]propan-1-one;methyl 3-amino-6-chloro-5-(triazol-2-yl)pyrazine-2-carboxylate;methyl 3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylate;(3-methylimidazo[1,2-a]pyridin-6-yl)boronic acid;[(2R)-oxolan-2-yl]methanamine;hydroxide.

What is the SMILES notation for lithium;3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazin-2-yl]-3-[(2R)-oxolan-2-yl]propan-1-one;methyl 3-amino-6-chloro-5-(triazol-2-yl)pyrazine-2-carboxylate;methyl 3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylate;(3-methylimidazo[1,2-a]pyridin-6-yl)boronic acid;[(2R)-oxolan-2-yl]methanamine;hydroxide?

The canonical SMILES for lithium;3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazin-2-yl]-3-[(2R)-oxolan-2-yl]propan-1-one;methyl 3-amino-6-chloro-5-(triazol-2-yl)pyrazine-2-carboxylate;methyl 3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylate;(3-methylimidazo[1,2-a]pyridin-6-yl)boronic acid;[(2R)-oxolan-2-yl]methanamine;hydroxide is COC(=O)c1nc(-c2ccc3ncc(C)n3c2)c(-n2nccn2)nc1N.COC(=O)c1nc(Cl)c(-n2nccn2)nc1N.Cc1cnc2ccc(-c3nc(C(=O)CC[C@H]4CCCO4)c(N)nc3-n3nccn3)cn12.Cc1cnc2ccc(-c3nc(C(=O)O)c(N)nc3-n3nccn3)cn12.Cc1cnc2ccc(B(O)O)cn12.NC[C@H]1CCCO1.[Li+].[OH-].

What is the InChIKey of lithium;3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazin-2-yl]-3-[(2R)-oxolan-2-yl]propan-1-one;methyl 3-amino-6-chloro-5-(triazol-2-yl)pyrazine-2-carboxylate;methyl 3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylate;(3-methylimidazo[1,2-a]pyridin-6-yl)boronic acid;[(2R)-oxolan-2-yl]methanamine;hydroxide?

The InChIKey is RWCPLPKFHYKNQP-BMKPWPAOSA-M. The full InChI is InChI=1S/C21H22N8O2.C16H14N8O2.C15H12N8O2.C8H9BN2O2.C8H7ClN6O2.C5H11NO.Li.H2O/c1-13-11-23-17-7-4-14(12-28(13)17)18-21(29-24-8-9-25-29)27-20(22)19(26-18)16(30)6-5-15-3-2-10-31-15;1-9-7-18-11-4-3-10(8-23(9)11)12-15(24-19-5-6-20-24)22-14(17)13(21-12)16(25)26-2;1-8-6-17-10-3-2-9(7-22(8)10)11-14(23-18-4-5-19-23)21-13(16)12(20-11)15(24)25;1-6-4-10-8-3-2-7(9(12)13)5-11(6)8;1-17-8(16)4-6(10)14-7(5(9)13-4)15-11-2-3-12-15;6-4-5-2-1-3-7-5;;/h4,7-9,11-12,15H,2-3,5-6,10H2,1H3,(H2,22,27);3-8H,1-2H3,(H2,17,22);2-7H,1H3,(H2,16,21)(H,24,25);2-5,12-13H,1H3;2-3H,1H3,(H2,10,14);5H,1-4,6H2;;1H2/q;;;;;;+1;/p-1/t15-;;;;;5-;;/m1....1../s1.

What are the key properties of lithium;3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazin-2-yl]-3-[(2R)-oxolan-2-yl]propan-1-one;methyl 3-amino-6-chloro-5-(triazol-2-yl)pyrazine-2-carboxylate;methyl 3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylate;(3-methylimidazo[1,2-a]pyridin-6-yl)boronic acid;[(2R)-oxolan-2-yl]methanamine;hydroxide?

lithium;3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazin-2-yl]-3-[(2R)-oxolan-2-yl]propan-1-one;methyl 3-amino-6-chloro-5-(triazol-2-yl)pyrazine-2-carboxylate;methyl 3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylate;(3-methylimidazo[1,2-a]pyridin-6-yl)boronic acid;[(2R)-oxolan-2-yl]methanamine;hydroxide has a molecular weight of 1660.84 g/mol, XLogP of 0.77, 16 rotatable bonds, 8 hydrogen bond donors, and 44 hydrogen bond acceptors.

Where does this data come from?

All data for lithium;3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazin-2-yl]-3-[(2R)-oxolan-2-yl]propan-1-one;methyl 3-amino-6-chloro-5-(triazol-2-yl)pyrazine-2-carboxylate;methyl 3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(triazol-2-yl)pyrazine-2-carboxylate;(3-methylimidazo[1,2-a]pyridin-6-yl)boronic acid;[(2R)-oxolan-2-yl]methanamine;hydroxide is sourced from PubChem (CID 160745245), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).